Backer v. Palisades Growth Capital

Supreme Court of Delaware·Decided January 15, 2021·No. 156, 2020·Published

Opinion

IN THE SUPREME COURT OF THE STATE OF DELAWARE

ALEX BÄCKER AND RICARDO § BÄCKER, § § No. 156, 2020

Defendants Below, § Appellants, § § Court Below – Court of Chancery v. § of the State of Delaware §

PALISADES GROWTH CAPITAL II, § C.A. No. 2019-0931-JRS L.P., § §

Plaintiff Below, § Appellee. § §

Submitted: October 21, 2020 Decided: January 15, 2021

Before SEITZ, Chief Justice; VALIHURA, VAUGHN, TRAYNOR, and MONTGOMERY-REEVES, Justices, constituting the Court en Banc.

Upon appeal from the Court of Chancery. AFFIRMED.

Thomas A. Uebler, Esquire (argued), Joseph L. Christensen, Esquire, and Hayley M. Lenahan, Esquire, MCCOLLOM D’EMILIO SMITH UEBLER LLC, Wilmington, Delaware; Attorneys for Appellants Alex Bäcker and Ricardo Bäcker.

Bradley R. Aronstam, Esquire (argued), Roger S. Stronach, Esquire, and Holly E. Newell, Esquire, ROSS ARONSTAM & MORITZ LLP, Wilmington, Delaware; Jon M. Talotta, Esquire, HOGAN LOVELLS US LLP, Tysons, Virginia; Michael C. Hefter, Esquire, HOGAN LOVELLS US LLP, New York, New York; Attorneys for Appellee Palisades Growth Capital II, L.P.

MONTGOMERY-REEVES, Justice:

Appellant Alex Bäcker is the co-founder and majority common stockholder of QLess, Inc. (“QLess” or the “Company”). In June 2019, the Company’s board removed Alex as CEO following an internal investigation into workplace complaints.1 Alex fought hard to keep his role as CEO, but eventually relented and expressed support for his successor, Kevin Grauman.

On November 15, 2019, QLess held a board meeting. In the week leading up to the meeting, the Company’s outside counsel circulated board resolutions that, among other things, would appoint Grauman to the board. Alex made a series of statements that collectively represented support for Grauman’s appointment.

On the eve of the board meeting, the Company’s independent director unexpectedly resigned, giving Alex a board majority. Alex leapt into action, devising a secret counter agenda to fire Grauman and lock-in Alex’s control of the Company. Alex caught his fellow directors by surprise at the meeting, passing his counter agenda over objections and seizing control of the Company.

Palisades Growth Capital II, L.P., the majority owner of the Company’s Series A preferred stock, filed a complaint in the Court of Chancery seeking to reverse Alex’s actions.

1 After initially identifying individuals, this Court references surnames without honorifics or regard to formal titles such as “Doctor.” The Court intends no disrespect. The Court also refers to Alex Bäcker and Ricardo Bäcker by their first names to avoid confusion. Again, the Court intends no disrespect and does not mean to suggest familiarity.

Following a paper trial, the court held that, even if technically legal, the board’s actions were invalid as a matter of equity because Alex affirmatively deceived a fellow director to establish a quorum.

Appellants raise four primary issues on appeal. First, Appellants argue that the Court of Chancery’s affirmative deception finding relied on clearly erroneous interpretations of the evidence. Second, Appellants argue that the court erred by imposing an equitable notice requirement for a regular board meeting, contrary to Delaware precedent. Third, Appellants argue that the deceived director’s participation in the meeting precludes equitable relief. Fourth, Appellants argue that the court erred by exercising its equitable powers to grant relief for a de facto breach of a stockholder voting agreement.

Having reviewed the parties’ briefs and the record on appeal, and after oral argument, this Court holds that the Court of Chancery’s finding of affirmative deception was not clearly erroneous. The Court also holds that the Court of Chancery did not impose an equitable notice requirement for regular board meetings, that Appellants failed to properly raise an equitable participation defense below, and that the Court of Chancery did not exercise its equitable powers to grant relief for a de facto breach of contract claim. Accordingly, this Court affirms the Court of Chancery’s March 26, 2020 Memorandum Opinion.

I. BACKGROUND2 A. The Parties and Relevant Non-Parties QLess is a privately held Delaware corporation headquartered in California.3 QLess produces and licenses a virtual queue management system that reduces the time that retail customers must wait in line for services.4 The Company has three primary stockholders: (i) Appellant Alex Bäcker, who owns the majority of the common stock, (ii) Respondent Palisades Growth Capital II, L.P. (“Palisades”), which owns the majority of the Series A preferred stock, and (iii) non-party Altos Hybrid 2 L.P. (“Altos”), which owns the majority of the Series A-1 preferred stock.5 Under the Company’s charter, the common stockholders have the exclusive right as a class to elect two directors.6 The Series A and Series A-1 preferred stockholders each have the exclusive right as a class to elect one director.7 The stockholders vote jointly on other board appointments.8 Alex co-founded QLess in 2009 and served as the Company’s CEO until June 2019.9 Alex, as the majority owner of the Company’s common stock, controls two board seats and

2 The Court takes the essential facts from the Court of Chancery’s Memorandum Opinion. Palisades Growth Cap. II, L.P. v. Backer, 2020 WL 1503218 (Del. Ch. Mar. 26, 2020). 3 Id. at *3. 4 Id. 5 Id. 6 Id. 7 Id. 8 See Appendix to the Opening Br. 47-48 (hereafter “A__”). 9 Palisades, 2020 WL 1503218, at *3.

appointed himself as a board member.10 Alex also appointed his father, Appellant Ricardo Bäcker, to the board in early 2019 to replace Michael Bell.11 Palisades is a private equity firm that first invested in QLess in August 2017.12 Palisades, as the majority owner of the Company’s Series A preferred stock, appointed Jeff Anderson, a partner of Palisades, to the board in 2017.13 Altos is an investment firm that first invested in QLess in November 2018.14 Altos, as the majority owner of the Company’s Series A-1 preferred stock, appointed Hodong Nam, co-founder of Altos, to the board in 2018. Nam resigned from the QLess board in September 2019.15 After resigning, Nam chose Paul D’Addario, a Senior Managing Director of Palisades, as his replacement on the board.16 Ivan Markman served as the Company’s independent director from November 2018 until he resigned in November 2019.17 Paul Alderton is the Company’s outside counsel.18

10 Id. at *1, *3. 11 Id. at *3. 12 Id. 13 Id. 14 Id. 15 Id. 16 Id. 17 Id. 18 Id. at *4.

Patricio Cuestra is the consultant that Alex and Ricardo purported to appoint as a common director during the November 15, 2019 board meeting.19 Kevin Grauman was hired as the Company’s CEO in September 2019 and purportedly was terminated during the November 15, 2019 board meeting.20 B. The Board Terminates Alex Bäcker as CEO In early 2019, QLess employees began reporting to the board that Alex’s leadership style was creating a toxic work environment.21 According to some senior executives, Alex was becoming “increasingly withdrawn and unhinged, either totally absent and disconnected or hyper micromanaging and combative.”22 At that time, the Company’s board was composed of five directors: Alex (common director), Michael Bell (common director), Anderson (Series A director), Nam (Series A-1 director), and Markman (independent director).23 The board grew concerned that the Company could suffer a mass employee exodus.24 Those concerns intensified when Alex terminated the Company’s Vice President of Engineering in March 2019, frustrating investors.25

19 Id. at *5, *5 n.60. 20 Id. at *3. 21 Id. 22 Id.; see also Appendix to Answering Br. 1 (hereafter “B__”). 23 See Palisades, 2020 WL 1503218, at *3-4. 24 Id. at *3. 25 Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Backer v. Palisades Growth Capital, (Del. 2021).

Backer v. Palisades Growth Capital (Backer v. Palisades Growth Capital) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Nixon v. Blackwell
626 A.2d 1366 (Supreme Court of Delaware, 1993)
Montgomery Cellular Holding Co. v. Dobler
880 A.2d 206 (Supreme Court of Delaware, 2005)
Fiduciary Trust Co. v. Fiduciary Trust Co.
445 A.2d 927 (Supreme Court of Delaware, 1982)
SmithKline Beecham Pharmaceuticals Co. v. Merck & Co., Inc.
766 A.2d 442 (Supreme Court of Delaware, 2000)
Nemec v. Shrader
991 A.2d 1120 (Supreme Court of Delaware, 2010)
Cede & Co. v. Technicolor, Inc.
758 A.2d 485 (Supreme Court of Delaware, 2000)
Schnell v. Chris-Craft Industries, Inc.
285 A.2d 437 (Supreme Court of Delaware, 1971)
Genger v. TR INVESTORS, LLC
26 A.3d 180 (Supreme Court of Delaware, 2011)
Schroder v. Scotten, Dillon Company
299 A.2d 431 (Court of Chancery of Delaware, 1972)
Bank of New York Mellon Trust Co. v. Liberty Media Corp.
29 A.3d 225 (Supreme Court of Delaware, 2011)
Mills Acquisition Co. v. MacMillan, Inc.
559 A.2d 1261 (Supreme Court of Delaware, 1989)
Sample v. Morgan
914 A.2d 647 (Court of Chancery of Delaware, 2007)
Schock v. Nash
732 A.2d 217 (Supreme Court of Delaware, 1999)
RBC Capital Markets, LLC v. Jervis
129 A.3d 816 (Supreme Court of Delaware, 2015)
CDX Holdings, Inc. v. Fox
141 A.3d 1037 (Supreme Court of Delaware, 2016)
In Re Investors Bancorp, Inc. Stockholder Litigation
177 A.3d 1208 (Supreme Court of Delaware, 2017)
SIGA Technologies, Inc. v. PharmAthene, Inc.
67 A.3d 330 (Supreme Court of Delaware, 2013)
Biolase, Inc. v. Oracle Partners, L.P.
97 A.3d 1029 (Supreme Court of Delaware, 2014)
Klaassen v. Allegro Development Corp.
106 A.3d 1035 (Supreme Court of Delaware, 2014)
Optimiscorp v. Waite
137 A.3d 970 (Supreme Court of Delaware, 2016)